Skip to main content
Erschienen in: Techniques in Coloproctology 7/2017

28.07.2017 | Controversies in Colorectal Surgery

Looking for the Good, Bad and the Ugly rectal cancers of the twenty-first century… or “How to avoid tears when peeling onions”

verfasst von: R. Glynne-Jones

Erschienen in: Techniques in Coloproctology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Excerpt

The management of patients with “locally advanced rectal cancer” (LARC) continues to evolve. Total mesorectal excision (TME) is the mainstay of curative treatment. Multiple randomised phase III trials showed that short-course preoperative radiotherapy (SCPRT) or chemoradiation (CRT) significantly reduced the rates of local recurrence compared to surgery alone [19]. Multidisciplinary teams (MDTs) take corporate decisions together on the optimal management. …
Literatur
1.
Zurück zum Zitat Sauer R, Becker H, Hohenberger W, Rodel C, German Rectal Cancer Study Group et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed Sauer R, Becker H, Hohenberger W, Rodel C, German Rectal Cancer Study Group et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740CrossRefPubMed
2.
Zurück zum Zitat Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336(14):980–987CrossRef Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336(14):980–987CrossRef
3.
Zurück zum Zitat Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:639–646CrossRef Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:639–646CrossRef
4.
Zurück zum Zitat Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123CrossRefPubMed Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L et al (2006) Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123CrossRefPubMed
5.
Zurück zum Zitat Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudełko M, Kryj M, Oledzki J, Szmeja J, Słuszniak J, Serkies K, Kładny J, Pamucka M, Kukołowicz P (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72(1):15–24CrossRefPubMed Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudełko M, Kryj M, Oledzki J, Szmeja J, Słuszniak J, Serkies K, Kładny J, Pamucka M, Kukołowicz P (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72(1):15–24CrossRefPubMed
6.
Zurück zum Zitat Bujko K, Nowacki MP, Nasierowska-Guttmejer et al (2006) Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223CrossRefPubMed Bujko K, Nowacki MP, Nasierowska-Guttmejer et al (2006) Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223CrossRefPubMed
7.
Zurück zum Zitat Gerard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–T4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625CrossRefPubMed Gerard JP, Conroy T, Bonnetain F, Bouché O, Chapet O, Closon-Dejardin MT et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3–T4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625CrossRefPubMed
8.
Zurück zum Zitat Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666):811–820CrossRefPubMedPubMedCentral Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666):811–820CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Roh MS, Colangelo LH, O’Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03. J Clin Oncol 27:5124–5130CrossRefPubMedPubMedCentral Roh MS, Colangelo LH, O’Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03. J Clin Oncol 27:5124–5130CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat São Julião GP, Habr Gama A, Vailati BB, Perez RO (2017) Looking for the Good, Bad and the Ugly rectal cancers of the 21st century. Tech Coloproctol São Julião GP, Habr Gama A, Vailati BB, Perez RO (2017) Looking for the Good, Bad and the Ugly rectal cancers of the 21st century. Tech Coloproctol
11.
Zurück zum Zitat Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRefPubMed Maas M, Nelemans PJ, Valentini V et al (2010) Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 11:835–844CrossRefPubMed
12.
Zurück zum Zitat Habr-Gama A, Sabbaga J, Gama-Rodrigues J et al (2013) Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 56(10):1109–1117CrossRefPubMed Habr-Gama A, Sabbaga J, Gama-Rodrigues J et al (2013) Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 56(10):1109–1117CrossRefPubMed
13.
Zurück zum Zitat Feddern ML, Jensen TS, Laurberg S (2015) Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life. A population-based, cross-sectional study. Pain 156(9):1765–1771CrossRefPubMed Feddern ML, Jensen TS, Laurberg S (2015) Chronic pain in the pelvic area or lower extremities after rectal cancer treatment and its impact on quality of life. A population-based, cross-sectional study. Pain 156(9):1765–1771CrossRefPubMed
14.
Zurück zum Zitat Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter. Eur Study Ann Surg 253:711–719CrossRef Taylor FG, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter. Eur Study Ann Surg 253:711–719CrossRef
15.
Zurück zum Zitat Glimelius B, Tiret E, Cervantes A, Arnold D, ESMO Guidelines Working Group (2013) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013(Suppl 6):vi81–vi88 Glimelius B, Tiret E, Cervantes A, Arnold D, ESMO Guidelines Working Group (2013) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013(Suppl 6):vi81–vi88
17.
Zurück zum Zitat National Clinical Practice Guidelines in Oncology (NCCN Guidelines): Rectal Cancer Version 2.2017 www.ncrn.org. Accessed 4/5/2017 National Clinical Practice Guidelines in Oncology (NCCN Guidelines): Rectal Cancer Version 2.2017 www.​ncrn.​org. Accessed 4/5/2017
18.
Zurück zum Zitat Valentini V, Gambacorta MA, Barbaro B, Chiloiro G, Coco C, Das P, Fanfani F, Joye I, Kachnic L, Maingon P, Marijnen C, Ngan S, Haustermans K (2016) International consensus guidelines on Clinical Target Volume delineation in rectal cancer. Radiother Oncol 120(2):195–201CrossRefPubMed Valentini V, Gambacorta MA, Barbaro B, Chiloiro G, Coco C, Das P, Fanfani F, Joye I, Kachnic L, Maingon P, Marijnen C, Ngan S, Haustermans K (2016) International consensus guidelines on Clinical Target Volume delineation in rectal cancer. Radiother Oncol 120(2):195–201CrossRefPubMed
19.
Zurück zum Zitat Habr-Gama A, São Julião GP, Gama-Rodrigues J, Vailati BB, Ortega C, Fernandez LM, Araújo SEA, Perez RO, Baseline T (2017) Classification predicts early tumor regrowth after nonoperative management in distal rectal cancer after extended neoadjuvant chemoradiation and initial complete clinical response. Dis Colon Rectum 60(6):586–594CrossRefPubMed Habr-Gama A, São Julião GP, Gama-Rodrigues J, Vailati BB, Ortega C, Fernandez LM, Araújo SEA, Perez RO, Baseline T (2017) Classification predicts early tumor regrowth after nonoperative management in distal rectal cancer after extended neoadjuvant chemoradiation and initial complete clinical response. Dis Colon Rectum 60(6):586–594CrossRefPubMed
20.
Zurück zum Zitat Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 23(24):5620–5627CrossRefPubMed Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 23(24):5620–5627CrossRefPubMed
21.
Zurück zum Zitat van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ, Dutch Colorectal Cancer Group (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582CrossRefPubMed van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ, Dutch Colorectal Cancer Group (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582CrossRefPubMed
22.
Zurück zum Zitat Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21(11):1350–1356CrossRefPubMedPubMedCentral Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C et al (2015) The consensus molecular subtypes of colorectal cancer. Nat Med 21(11):1350–1356CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Battersby NJ, Bouliotis G, Emmertsen KJ, Juul T, Glynne-Jones R, Branagan G, Christensen P, Laurberg S, Moran BJ, UK and Danish LARS Study Groups (2017) Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score. Gut. doi:10.1136/gutjnl-2016-312695 Battersby NJ, Bouliotis G, Emmertsen KJ, Juul T, Glynne-Jones R, Branagan G, Christensen P, Laurberg S, Moran BJ, UK and Danish LARS Study Groups (2017) Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score. Gut. doi:10.​1136/​gutjnl-2016-312695
Metadaten
Titel
Looking for the Good, Bad and the Ugly rectal cancers of the twenty-first century… or “How to avoid tears when peeling onions”
verfasst von
R. Glynne-Jones
Publikationsdatum
28.07.2017
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 7/2017
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-017-1661-5

Weitere Artikel der Ausgabe 7/2017

Techniques in Coloproctology 7/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.